Division of Reconstructive Surgery for Oral and Maxillofacial Region, Department of Tissue Regeneration and Reconstruction, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
PLoS One. 2019 Nov 21;14(11):e0225472. doi: 10.1371/journal.pone.0225472. eCollection 2019.
Growth factors in serum-free conditioned media from human bone marrow-derived mesenchymal stem cells (MSC-CM) are known to be effective in bone regeneration. However, the secretomes in MSC-CM that act as active ingredients for bone regeneration, as well as their mechanisms, remains unclear. Exosomes, components of MSC-CM, provide the recipient cells with genetic information and enhance the recipient cellular paracrine stimulation, which contributes to tissue regeneration. We hypothesized that MSC-CM-derived exosomes (MSC-Exo) promoted bone regeneration, and that angiogenesis was a key step. Here, we prepared an MSC-Exo group, MSC-CM group, and Exo-antiVEGF group (MSC-Exo with angiogenesis inhibitor), and examined the osteogenic and angiogenic potential in MSCs. Furthermore, we used a rat model of calvaria bone defect and implanted each sample to evaluate bone formation weekly, until week 4 after treatment. Results showed that MSC-Exo enhanced cellular migration and osteogenic and angiogenic gene expression in MSCs compared to that in other groups. In vivo, early bone formation by MSC-Exo was also confirmed. Two weeks after implantation, the newly formed bone area was 31.5 ± 6.5% in the MSC-Exo group while those in the control and Exo-antiVEGF groups were 15.4 ± 4.4% and 8.7 ± 1.1%, respectively. Four weeks after implantation, differences in the area between the MSC-Exo group and the Exo-antiVEGF or control groups were further broadened. Histologically, notable accumulation of osteoblast-like cells and vascular endothelial cells was observed in the MSC-Exo group; however, fewer cells were found in the Exo-antiVEGF and control groups. In conclusion, MSC-Exo promoted bone regeneration during early stages, as well as enhanced angiogenesis. Considering the tissue regeneration with transplanted cells and their secretomes, this study suggests that exosomes might play an important role, especially in angiogenesis.
已知无血清条件培养基中的生长因子(MSC-CM)对骨再生有效。然而,作为骨再生活性成分的 MSC-CM 分泌组及其机制仍不清楚。MSC-CM 的成分外泌体为受体细胞提供遗传信息,并增强受体细胞的旁分泌刺激,从而促进组织再生。我们假设 MSC-CM 衍生的外泌体(MSC-Exo)促进骨再生,并且血管生成是关键步骤。在此,我们制备了 MSC-Exo 组、MSC-CM 组和 Exo-antiVEGF 组(含血管生成抑制剂的 MSC-Exo),并检查了 MSC 中的成骨和成血管潜能。此外,我们使用大鼠颅骨骨缺损模型,植入每种样本,每周评估一次骨形成,直至治疗后第 4 周。结果表明,与其他组相比,MSC-Exo 增强了 MSC 中的细胞迁移和成骨和成血管基因表达。在体内,也证实了 MSC-Exo 早期骨形成。植入后 2 周,MSC-Exo 组新形成的骨面积为 31.5±6.5%,而对照组和 Exo-antiVEGF 组分别为 15.4±4.4%和 8.7±1.1%。植入后 4 周,MSC-Exo 组与 Exo-antiVEGF 组或对照组之间的面积差异进一步扩大。组织学上,在 MSC-Exo 组中观察到大量成骨样细胞和血管内皮细胞的聚集;然而,在 Exo-antiVEGF 和对照组中发现的细胞较少。总之,MSC-Exo 促进了早期骨再生,并增强了血管生成。考虑到移植细胞及其分泌组的组织再生,本研究表明外泌体可能发挥重要作用,尤其是在血管生成方面。